Osanetant

DRUG2 trials

Sponsors

University of Kansas Medical Center

Conditions

Prostate Adenocarcinoma

Early Phase 1

Pilot of Osanetant to Reduce Testosterone in Men With Adenocarcinoma of the Prostate

TerminatedNCT05607342

University of Kansas Medical CenterProstate Adenocarcinoma

Start: 2023-01-03End: 2023-11-06Updated: 2024-02-21

Pilot of Osanetant to Reduce Severity of Hot Flashes in Men With Adenocarcinoma of the Prostate

WithdrawnNCT05647447

University of Kansas Medical CenterProstate Adenocarcinoma

Start: 2023-01-03End: 2023-10-05Updated: 2024-02-21